Trends in the Use of Antipsychotics for Off-Label Indications: Clinical and Ethical Considerations
Biomedical & Pharmacology Journal · 31.12.2025 · 4 (18) · 2504
DOI: 10.13005/bpj/3273 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical & Pharmacology Journal, online erschienen am 30.12.2025. Verfasst von Muhammad Irfan Siddique und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The use of antipsychotic drugs has expanded beyond their approved indications for schizophrenia and bipolar disorder to include conditions such as insomnia, anxiety, dementia-related behavioral disorders, and pediatric behavioral issues. This review examines prescribing trends, clinical motivations, and ethical concerns surrounding the use of antipsychotic medications across different populations. Second-generation agents—such as risperidone, quetiapine, olanzapine, and aripiprazole—are preferred for off-label use due to their favorable side-effect profiles and reduced risk of extrapyramidal symptoms. However, off-label prescriptions often lack robust supporting evidence, increasing the risk of metabolic syndrome, cardiovascular complications, cognitive decline, and higher mortality among vulnerable patients. Drivers of off-label use include limited approved options, physician practice patterns, and pharmaceutical promotion. Ethical prescribing requires evidence-based justification, informed consent, and vigilant monitoring. This review underscores the need for stricter regulatory guidelines, stronger evidence, and a patient-centered approach to safeguard responsible off-label use of antipsychotic medications.
Zitieren
APA
Siddique, M. I., Ahmad, S., & khan, A. (2025). Trends in the Use of Antipsychotics for Off-Label Indications: Clinical and Ethical Considerations. Biomedical & Pharmacology Journal, 4(18), 2504. https://doi.org/10.13005/bpj/3273
Vancouver
Siddique MI, Ahmad S, khan A. Trends in the Use of Antipsychotics for Off-Label Indications: Clinical and Ethical Considerations. Biomedical & Pharmacology Journal. 2025;4(18):2504. doi:10.13005/bpj/3273
BibTeX
@article{Siddique2025,
author = {Siddique, Muhammad Irfan and Ahmad, Shakeel and khan, Abida},
title = {Trends in the Use of Antipsychotics for Off-Label Indications: Clinical and Ethical Considerations},
journal = {Biomedical & Pharmacology Journal},
year = {2025},
volume = {4},
number = {18},
pages = {2504},
doi = {10.13005/bpj/3273}
}
EUVIMED